Indegene Subsidiary's US Lawsuit Settlement Gets Preliminary Court Approval

Indegene Limited has announced a material development regarding an ongoing class-action lawsuit pending against its wholly-owned overseas subsidiary, Indegene, Inc., before the U.S. District Court, District of New Jersey. The Court issued an order on 27 August 2026, preliminarily approving the proposed class action settlement entered into between the parties.

The Court has also approved the proposed notice process, appointed Analytics as the Settlement Administrator, and scheduled the final approval hearing for 12 January 2027. The preliminary approval order does not constitute a final approval of the settlement; it remains subject to the completion of the Court-approved notice and claims process and final approval by the Court.

Further details provided in Annexure-I indicate that the settlement framework includes a maximum settlement fund of approximately USD 4.72 million (₹39.2 crore). Eligible claimants will receive USD 250 per approved claim, with actual payments dependent on the number of valid claims received and approved. Amounts not required for approved claims and other settlement payments will be retained or reverted to the defendants. No payment has been made to class members at this stage, and the actual financial impact will depend on the number of valid claims, administration costs, and other payable amounts. The litigation is against Indegene, Inc. and certain subsidiaries and does not involve the company's key managerial personnel or ultimate person in control.